ST
VRTX icon

Spot Trading’s Vertex Pharmaceuticals VRTX Stock Holding History

Spot Trading’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$4.45M Buy
29,281
+10,728
+58% +$1.61M 0.08% 320
2017
Q2 		$2.39M Buy
18,553
+18,382
+10,750% +$2.21M 0.05% 563
2017
Q1 		$19K Buy
+171
New +$15.1K ﹤0.01% 2685
2016
Q1 		– Sell
-4,424
Closed -$557K – 4018
2015
Q4 		$557K Sell
4,424
-3,184
-42% -$384K 0.01% 1850
2015
Q3 		$792K Sell
7,608
-1,957
-20% -$251K 0.01% 1755
2015
Q2 		$1.18M Buy
9,565
+336
+4% +$42.3K 0.01% 1518
2015
Q1 		$1.09M Buy
9,229
+8,845
+2,303% +$1.06M 0.01% 1531
2014
Q4 		$46K Sell
384
-17,106
-98% -$1.93M ﹤0.01% 3465
2014
Q3 		$1.96M Buy
17,490
+6,658
+61% +$634K 0.01% 1566
2014
Q2 		$1.03M Sell
10,832
-9,407
-46% -$660K ﹤0.01% 2111
2014
Q1 		$1.43M Sell
20,239
-51,012
-72% -$4.04M 0.01% 1763
2013
Q4 		$5.29M Sell
71,251
-11,193
-14% -$779K 0.03% 823
2013
Q3 		$6.25M Sell
82,444
-38,904
-32% -$3.1M 0.04% 592
2013
Q2 		$9.71M Buy
+121,348
New +$8.94M 0.06% 381

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Spot Trading's VRTX Position: Q3 2017 in Review

Spot Trading increased its Vertex Pharmaceuticals (VRTX) stake by 58% in Q3 2017, buying an estimated $1.61M and bringing the position to 29,281 shares worth $4.45M. The position accounts for 0.08% of the portfolio, ranked #320.

Spot Trading first reported a position in VRTX in Q2 2013 and has held it in 14 quarters since. The position peaked at $9.71M in Q2 2013. 611 funds tracked by Wall St. Rank hold VRTX as of Q3 2017.

  • Spot Trading held 29,281 shares of Vertex Pharmaceuticals worth $4.45M as of Q3 2017.
  • Spot Trading bought 10,728 Vertex Pharmaceuticals shares in Q3 2017, an estimated $1.61M.
  • Vertex Pharmaceuticals made up 0.08% of Spot Trading's portfolio in Q3 2017, its #320 holding.
  • Spot Trading first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • Spot Trading's Vertex Pharmaceuticals position peaked at $9.71M in Q2 2013.
  • 611 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.